Co-Author
This page shows the publications co-authored by Nancy Cho and Monica Bertagnolli.
Connection Strength
2.239
-
Immunohistochemical and molecular analysis of tyrosine kinase activity in desmoid tumors. J Surg Res. 2012 Apr; 173(2):320-6.
Score: 0.453
-
Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila). 2008 Jun; 1(1):21-31.
Score: 0.378
-
Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res. 2007 Mar 01; 67(5):2366-72.
Score: 0.350
-
Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH. Cancer Epidemiol Biomarkers Prev. 2018 07; 27(7):728-736.
Score: 0.190
-
Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras/MEK/ERK and PI3K/Akt/mTOR pathways. Carcinogenesis. 2018 05 03; 39(5):681-688.
Score: 0.190
-
Antitumor effects of hyaluronan inhibition in desmoid tumors. Carcinogenesis. 2015 Feb; 36(2):272-9.
Score: 0.151
-
Lack of anti-tumor activity with the ß-catenin expression inhibitor EZN-3892 in the C57BL/6J Min/+ model of intestinal carcinogenesis. Biochem Biophys Res Commun. 2014 Feb 14; 444(3):283-9.
Score: 0.141
-
Estrogen receptor a or ß loss in the colon of Min/+ mice promotes crypt expansion and impairs TGFß and HNF3ß signaling. Carcinogenesis. 2014 Jan; 35(1):96-102.
Score: 0.138
-
Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors. Cancer Res. 2012 Jan 01; 72(1):346-55.
Score: 0.121
-
Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor. Cancer Res. 2006 Jun 15; 66(12):6432-8.
Score: 0.083
-
Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation. Pigment Cell Melanoma Res. 2016 11; 29(6):656-668.
Score: 0.042
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.